¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"half value layer"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • biological half life
    »ý¹°ÇÐÀû¹Ý°¨±â
  • half bath
    ¹Ý½Å¸ñ¿å, ¹Ý½Å¿å
  • half elimination rate
    ¹Ý°¨·ü
  • half shell crown
    ¹Ý±Ý°ü
  • half survival time
    ¹Ý°¨»ýÁ¸½Ã°£
  • half-axial projection
    ¹ÝÃ༺Åõ»ç
  • half-life
    ¹Ý°¨±â
  • half-normal saline
    1/2»ý¸®½Ä¿°¼ö
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • basal layer
    ¹Ù´ÚÃþ, ±âÀúÃþ
  • buffy layer
    ¿¬Ãþ
  • circular layer
    µ¹¸²Ãþ
  • clear layer
    Åõ¸íÃþ
  • compact layer
    Ä¡¹ÐÃþ
  • cone cell layer
    ¿ø»Ô¼¼Æ÷Ãþ, ¿øÃß¼¼Æ÷Ãþ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crossover value
    ±³Â÷°ª
  • effective value
    À¯È¿°ª
  • end dilution value
    ü¿ÜÈñ¼®Ä¡
  • group reference value
    Áý´Ü±âÁØÄ¡
  • individualized reference value
    °³º°ÀûÂü°íÄ¡
  • maximum allowable value
    ÃÖ´ëÇã¿ëÄ¡
  • molar buffer value
    ¸ô¿ÏÃæ°¡
  • normal value
    Á¤»óÄ¡
  • positive predictive value
    ¾ç¼º¿¹ÃøÄ¡
  • predictive value
    ¿¹ÃøÄ¡
  • resource based relative value scale
    Áö¿ø±âÁØ»ó´ë°¡Ä¡
  • spatial value
    °ø°£°¡
  • symbolic value
    »ó¡°¡Ä¡
  • value system
    °¡Ä¡Ã¼°è
  • threshold value
    ¹®Åΰª, ¿ªÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • principal value of strain
    ¿ÖÁÖÄ¡(èàñ«öÇ).
  • recombination value
    Àç°áÇÕ°ª.
  • antibody half-life
    Ç×ü¹Ý°¨±â(ù÷ô÷ÚâÊïÑ¢).
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • half bath
    ¹Ý½Å¿å(Úâãóé±).
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
  • half lethal dose
    ¹ÝÄ¡»ç·®(ÚâöÈÞÝåÖ).
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • half round tube
    ¹Ý¿ø°ü(Úâê­Î·) ±³Á¤¿ë(ÎìïáéÄ) .
  • half round wire
    ¹Ý¿ø¼±(Úâê­àÊ) ±³Á¤¿ë .
  • half shell crown
    ¹Ý±Ý°ü.
  • half spherical cavity
    ¹Ý±¸Çü¿Íµ¿(ÚâϹû¡èÀ÷Ó).
  • half survival time
    ¹Ý°¨ÀÜ»ý¼ö¸í(ËÑ˧ ËÛËÎ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • effective half-life
    À¯È¿¹Ý°¨±â
  • elimination half-life
    ¼Ò½Ç¹Ý°¨±â.
  • half Fourier imaging
    ¹Ý Fourier ¿µ»ó
  • half bath
    ¹Ý½Å¿å(Úâãóé±).
  • half elimination rate
    1/2Á¦°ÅÀ²(ð¶ËÛëÒ), ¹Ý°¨·ü(ÚâÊõ×Ë)
  • half elimination rate
    1/2Á¦°ÅÀ², ¹Ý°¨·ü.
  • half fat cheese
    ¹ÝÅ»ÁöÄ¡ÀÌÁî.
  • half lethal dose
    ¹ÝÄ¡»ç·®(ÚâöÈÞÝåÖ).
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • half round tube
    ¹Ý¿ø°ü(Úâê­Î·) ±³Á¤¿ë(ÎìïáéÄ) .
  • half round wire
    ¹Ý¿ø¼±(Úâê­àÊ) ±³Á¤¿ë .
  • half shell crown
    ¹Ý±Ý°ü.
  • half spherical cavity
    ¹Ý±¸Çü¿Íµ¿(ÚâϹû¡èÀ÷Ó).
  • half survival time
    ¹Ý°¨ÀÜ»ý¼ö¸í(ËÑ˧ ËÛËÎ).
  • half survival time
    ¹Ý°¨ÀÜ»ý¼ö¸í(ÚâÊõíÑßæáøÙ¤).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Muscle layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Muscular layer
    ±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] ±ÙÃþ
  • Myoelastic layer
    ±ÙÀ°Åº·ÂÃþ
    [¿¾ ¿ë¾î] ±Ùź·ÂÃþ
  • Pretracheal layer
    ±â°ü¾ÕÃþ
    [¿¾ ¿ë¾î] ±â°üÀü¿±
  • Deep layer
    ±íÀºÃþ
    [¿¾ ¿ë¾î] ½É´ë
  • Deep layer
    ±íÀºÃþ
    [¿¾ ¿ë¾î] ½É¿±
  • Visceral layer [Epicardium]
    ³»ÀåÂÊÃþ [½ÉÀå¹Ù±ù¸·]
    [¿¾ ¿ë¾î] ÀåÃøÆÇ(½É¿Ü¸·)
  • Subendothelial layer
    ³»ÇǹØÃþ
    [¿¾ ¿ë¾î] ³»ÇÇÇÏÃþ
  • Ependymal layer
    ³ú½Ç¸·Ãþ
    [¿¾ ¿ë¾î] »óÀÇÃþ
  • Circular muscle layer
    µ¹¸²±ÙÀ°Ãþ
    [¿¾ ¿ë¾î] À±ÁÖ±ÙÃþ
  • Circular layer
    µ¹¸²Ãþ
    [¿¾ ¿ë¾î] À±ÁÖ±ÙÃþ
  • Circular layer
    µ¹¸²Ãþ
    [¿¾ ¿ë¾î] À±ÁÖÃþ
  • Posterior layer
    µÚÃþ
    [¿¾ ¿ë¾î] ÈÄ¿±
  • Supravascular layer
    ¸Æ°üÀ§Ãþ
    [¿¾ ¿ë¾î] ¸Æ°ü»óÃþ
  • Vascular layer
    ¸Æ°üÃþ
    [¿¾ ¿ë¾î] ¸Æ°üÃþ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • thin-layer gel filtration
    ¹ÚÃþ(ÚÝöµ) Á©¿©°ú(ÕëΦ)
  • biological half-life
    »ý¹°ÇÐÀû ¹Ý°¨±â(ßæÚªùÊîÜÚâÊõÑ¢)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • half-band width
    ¹Ý¶ì ³Êºñ
  • half-cell
    ¹Ý½Ç(Úâãø)
  • half-life
    ¹Ý°¨±â(ÚâÊõÑ¢)
  • half-of-the-sites reactivity
    ¹Ý(Úâ)ÀÚ¸® ¹ÝÀÀ¼º (Úãëëàõ)
  • half-period
    ¹Ý±â°£(ÚâÑ¢Êà)
  • half-reaction
    ¹Ý¹ÝÀÀ(ÚâÚãëë)
  • half-reaction time
    ¹Ý¹ÝÀÀ ½Ã°£(ÚâÚãëëãÁÊà)
  • half-site editing
    ¹Ý(Úâ)ÀÚ¸® ÆíÁý(øºòþ)
  • half-thickness
    ¹Ý°¨(ÚâÊõ) µÎ²²
  • half-time
    ¹Ý ½Ã°£(ÚâãÁÊà)
  • half-wave potential
    ¹ÝÆÄ ÀüÀ§(Úâ÷îï³êÈ)
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â(Úª×âîÜÚâÊõÑ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • half lethal dose
    ¹ÝÄ¡»ç·®
  • physical half-life
    ¹°¸®Àû ¹Ý°¨±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
TVL tenth value layer; tunica vasculosa lentis
HVT half-value thickness; herpesvirus of turkeys
GL gland; glomerular layer; glycolipid; glycosphingolipid; glycyrrhizin; greatest length; gustatory lac...
GLH germinal layer hemorrhage; giant lymph node hyperplasia
IPL inner plexiform layer; intrapleural
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HRT Half-relaxation time
T 1/2 Half-time
PHT Pressure Half Time
T(1/2) Terminal half-life
T 1/2 The biological half life
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • boundary value
    °æ°èÄ¡
  • correction value
    º¸Á¤Ä¡
  • fasting value
    °øº¹Ä¡
  • mean value
    Æò±ÕÄ¡
  • molar buffer value
    ¸ô ¿ÏÃæ°¡
  • negative predictive value
    À½¼º ¿¹»óÄ¡
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • observed value
    °üÃøÄ¡
  • osmotic value
    »ïÅõ °ª
  • symbolic value
    »ó¡ °¡Ä¡
  • threshold value
    ¿ªÄ¡
    ½Å°æÀ̳ª ±ÙÀ° µî¿¡ ¹ÝÀÀÀ» ÀÏÀ¸Å°´Â µ¥ ÇÊ¿äÇÑ ÃÖ¼Ò ÀÚ±Ø °ª. ÃÖ¼Ò ÇÑ°è °ªÀ̶ó°íµµ ÇÑ´Ù. ÀÛ¿ë ¿øÀο¡ µû¶ó ¿ªÄ¡ÀÇ Á¾·ùµµ ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ÀÚ±Ø ÀÛ¿ëÀÏ ¶§´Â ÀڱؿªÀ̶ó Çϰí, ±× Áß¿¡¼­µµ °¨°¢ Á¾·ù¿¡ µû¶ó ½Ã°¢¿ª, û°¢¿ªÀ̶ó°í ºÎ¸¥´Ù. ÀÌµé °ªÀº »ýü°¡ ÀÚ±ØÀ» ¹Þ¾Æ ÈïºÐÀ» ³ªÅ¸³»´Â ´É·Â, Áï ÈïºÐ¼ºÀÇ Ã´µµ·Î »ïÀ» ¼öµµ ÀÖ´Ù. ÀÚ±Ø È¿°ú´Â ±× °­µµ»Ó ¾Æ´Ï¶ó, ÀÚ±ØÀÇ Áö¼Ó ½Ã°£À̳ª °­µµÀÇ ½Ã°£Àû °æ°ú¿¡ µû¶ó Á¿ìµÈ´Ù. ¶Ç, ¼Ò¸®³ª ºû°ú °°ÀÌ ÀÛ¿ë ¿øÀÎÀÇ ¾çÀûÀÎ Â÷°¡ ÀÚ±Ø È¿°ú¿Í °°Àº °æ¿ì´Â ½Äº°¿ªÀ̶óµçÁö ±¸º°¿ªÀ̶ó Çϰí, ¾çÀûÀÎ Â÷¸¦ ¹®Á¦ ½ÃÇÏÁö ¾Ê´Â ÀÏ¹Ý ¿ªÄ¡¸¦ ´Ü¼ø¿ªÀ̶ó°í ÇÑ´Ù.
  • value judgement
    °¡Ä¡ ÆÇ´Ü
  • adipose layer
    Áö¹æ Ãþ
  • aponeurotic layer
    °Ç¸· Ãþ
  • basal epithelial layer
    ±âÀú »óÇÇ Ãþ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
half-chair form See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
half cystine Refers to one-half of a cystine molecule or of a cystinyl residue in a protein or peptide.
(05 Mar 2000)
half-deck 1. <zoology> A shell of the genus Crepidula; a boat shell. See Boat shell.
2. See Half deck, under Deck.
Source: Websters Dictionary
(01 Mar 1998)
half-fish <zoology> A salmon in its fifth year of growth.
Source: Websters Dictionary
(01 Mar 1998)
half-glass spectacles Spectacles, used for reading, in which the upper portion of the lenses are removed.
Synonym: clerical spectacles, pantoscopic spectacles, pulpit spectacles.
(05 Mar 2000)
half-hapten A substance that elicits an antigen-antibody reaction, but no precipitation.
(05 Mar 2000)
half-hearted 1. Wanting in heart or spirit; ungenerous; unkind.
2. Lacking zeal or courage; lukewarm. (H. James)
Source: Websters Dictionary
(01 Mar 1998)
half-inferior <plant biology> Of an ovary, partly below and partly above the level of attachment of the perianth and stamens.
(13 Nov 1997)
half-life 1. <pharmacology> The period over which the concentration of a specified chemical or drug takes to fall to half its original concentration in the specified fluid or blood.
2. <radiobiology> The time required to reduce the amount of a radionuclide to one-half the amount originally present. Physical or radioactive half-life refers to reduction of activity by radioactive decay, biological half-life refers to biological elimination from the body and effective half-life refers to the combined action of radioactive decay and biological elimination.
(16 Dec 1997)
half-moon 1. The moon at the quarters, when half its disk appears illuminated.
2. The shape of a half-moon; a crescent. "See how in warlike muster they appear, In rhombs, and wedges, and half-moons, and wings." (Milton)
3. An outwork composed of two faces, forming a salient angle whose gorge resembles a half-moon; now called a ravelin.
4. <zoology> A marine, sparoid, food fish of California (Caesiosoma Californiense). The body is ovate, blackish above, blue or gray below.
Synonym: medialuna.
Source: Websters Dictionary
(01 Mar 1998)
half-ray <geometry> A straight line considered as drawn from a center to an indefinite distance in one direction, the complete ray being the whole line drawn to an indefinite distance in both directions.
Source: Websters Dictionary
(01 Mar 1998)
half-reactions <chemistry> The two parts of an oxidation-reduction reaction, one representing oxidation, the other reduction.
(09 Jan 1998)
half register <molecular biology> A misalignment between two identical sets of repeating units of nucleotides within two copies of the same chromosome (one set of repeating units per copy of the chromosome), where repeating unit A from one set is inappropriately aligned with repeating unit B on the other set, so that ABABAB on one set would be aligned with BABABA on the other set instead of the correct ABABAB with ABABAB.
(13 Nov 1997)
half-tetrad analysis <genetics> The analysis of tetrad chromosomes (a pair of homologous chromosomes, thus four total chromosomes) after recombination when only half of the tetrad (two of the four chromosomes) can be analysed.
(13 Nov 1997)
half-time The time, in a first-order chemical (or enzymic) reaction, for half of the substance (substrate) to be converted or to disappear.
Compare: half-life.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • scarcity value
    Èñ¼Ò °¡Ä¡.
  • value
    °¡Ä¡,Æò°¡ÇÏ´Ù
  • R-value
    (resistance value)°ÇÃàÀç·áµîÀÇ ´Ü¿­¼º´ÉÄ¡
  • absolute value
    Àý´ë°ª
  • atomic value
    ¿øÀÚ°¡
  • atonic value
    ¿øÀÚ°¡
  • book value
    ÀåºÎ°¡°Ý
  • calorific value
    ¹ß¿­·®
  • cash (surrender) value
    ÇØ¾à ¹Ýȯ±Ý(º¸Çè °è¾à ÇØ¾à½Ã ¹ÝȯµÇ´Â ±Ý¾×)
  • exchange value
    (°æ)±³È¯ °¡Ä¡
  • expected value
    (Åë°è)±â´ë°ª
  • face value
    ¾×¸é °¡°Ý;±Ç¸é¾×;¾×¸é(Ç¥¸é)»óÀÇ °¡Ä¡(ÀǹÌ)
  • food value
    (½ÄǰÀÇ) ¿µ¾ç°¡
  • market value
    ½ÃÀå °¡°Ý
  • market value GNP
    ½Ã°¡ ±âÁØÀÇ ±¹¹Î ÃÑ»ý»ê 
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á